[The functional activity of the thrombocytes in chronic diseases of the large intestine]

Khirurgiia
|April 1, 1992
PubMed

Insights

Chronic large intestine diseases involve significant changes in blood platelet function, with recurrence linked to platelet activation. Treatments like Trental aim to correct these disorders, improving patient outcomes.

Area of Science:

  • Gastroenterology
  • Hematology
  • Internal Medicine

Background:

  • Chronic large intestine diseases, including colitis and amebiasis, present complex clinical challenges.
  • These conditions are associated with notable alterations in blood platelet activity and regulatory factors.

Purpose of the Study:

  • To investigate the role of blood platelet functional activity in the pathogenesis of chronic large intestine diseases.
  • To evaluate the impact of treatment on platelet function and disease dynamics.
  • To explore the significance of biogenic amines and cyclic adenosine monophosphate (cAMP) in disease development.

Main Methods:

  • Analysis of blood platelet functional activity and regulatory factors in patients with chronic large intestine diseases.
  • Monitoring disease dynamics before and after operative and nonoperative treatments.
  • Assessment of the effects of Trental and contrycal on platelet function and clinical symptoms.

Main Results:

  • Marked changes in blood platelet functional activity were observed in patients with chronic large intestine diseases.
  • Disease recurrence correlated with increased blood platelet activation.
  • Treatment with Trental and contrycal led to improvements in some patients, suggesting a role in correcting platelet dysfunction.

Conclusions:

  • Blood platelet functional activity and its regulation are crucial in the development and progression of chronic large intestine diseases.
  • Platelet activation is a key indicator of disease recurrence.
  • Biogenic amines and cAMP may represent universal mechanisms underlying these gastrointestinal disorders.

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...